nodes	percent_of_prediction	percent_of_DWPC	metapath
Abacavir—UGT1A1—Pazopanib—kidney cancer	0.216	0.436	CbGbCtD
Abacavir—UGT1A1—Erlotinib—kidney cancer	0.154	0.311	CbGbCtD
Abacavir—UGT1A1—Sorafenib—kidney cancer	0.125	0.253	CbGbCtD
Abacavir—ADH6—Ethanol oxidation—ALDH1A1—kidney cancer	0.0246	0.177	CbGpPWpGaD
Abacavir—ADH6—Fatty Acid Omega Oxidation—ALDH1A1—kidney cancer	0.0169	0.122	CbGpPWpGaD
Abacavir—ADH6—nephron tubule—kidney cancer	0.0158	0.163	CbGeAlD
Abacavir—ADH6—renal system—kidney cancer	0.0144	0.148	CbGeAlD
Abacavir—ADH6—kidney—kidney cancer	0.0139	0.144	CbGeAlD
Abacavir—ADH6—cortex of kidney—kidney cancer	0.0135	0.14	CbGeAlD
Abacavir—UGT1A1—urine—kidney cancer	0.0134	0.139	CbGeAlD
Abacavir—ADK—Purine salvage—APRT—kidney cancer	0.0125	0.0902	CbGpPWpGaD
Abacavir—ADK—Purine metabolism—PPAT—kidney cancer	0.00639	0.0461	CbGpPWpGaD
Abacavir—ADH6—Fatty Acid Omega Oxidation—CYP1A1—kidney cancer	0.00599	0.0432	CbGpPWpGaD
Abacavir—ADK—Purine metabolism—APRT—kidney cancer	0.00594	0.0428	CbGpPWpGaD
Abacavir—ADH6—Phase 1 - Functionalization of compounds—ALDH1A1—kidney cancer	0.00475	0.0343	CbGpPWpGaD
Abacavir—ADH6—Biological oxidations—ACY1—kidney cancer	0.00461	0.0332	CbGpPWpGaD
Abacavir—ADK—nephron tubule—kidney cancer	0.00367	0.0378	CbGeAlD
Abacavir—ADK—renal system—kidney cancer	0.00333	0.0344	CbGeAlD
Abacavir—UGT1A1—renal system—kidney cancer	0.00329	0.0339	CbGeAlD
Abacavir—ADK—kidney—kidney cancer	0.00322	0.0333	CbGeAlD
Abacavir—ADK—Nucleotide metabolism—PPAT—kidney cancer	0.00321	0.0231	CbGpPWpGaD
Abacavir—UGT1A1—kidney—kidney cancer	0.00318	0.0328	CbGeAlD
Abacavir—ADK—cortex of kidney—kidney cancer	0.00314	0.0324	CbGeAlD
Abacavir—ADK—gonad—kidney cancer	0.00299	0.0309	CbGeAlD
Abacavir—ADK—cardiac atrium—kidney cancer	0.00298	0.0308	CbGeAlD
Abacavir—ADK—Nucleotide metabolism—APRT—kidney cancer	0.00298	0.0215	CbGpPWpGaD
Abacavir—UGT1A1—Porphyrin metabolism—ALAD—kidney cancer	0.00266	0.0192	CbGpPWpGaD
Abacavir—ADH6—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	0.00262	0.0189	CbGpPWpGaD
Abacavir—ADH6—Biological oxidations—ALDH1A1—kidney cancer	0.00252	0.0182	CbGpPWpGaD
Abacavir—UGT1A1—Codeine and Morphine Metabolism—ABCB1—kidney cancer	0.00179	0.0129	CbGpPWpGaD
Abacavir—ADH6—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	0.00169	0.0122	CbGpPWpGaD
Abacavir—UGT1A1—Irinotecan Pathway—BCHE—kidney cancer	0.00152	0.0109	CbGpPWpGaD
Abacavir—ADH6—Biological oxidations—GSTT1—kidney cancer	0.00148	0.0107	CbGpPWpGaD
Abacavir—ADH6—Biological oxidations—PTGS1—kidney cancer	0.00139	0.01	CbGpPWpGaD
Abacavir—ADH6—Phase 1 - Functionalization of compounds—POMC—kidney cancer	0.00126	0.00906	CbGpPWpGaD
Abacavir—ADH6—Biological oxidations—GSTP1—kidney cancer	0.00103	0.00741	CbGpPWpGaD
Abacavir—ADH6—Biological oxidations—GSTM1—kidney cancer	0.000945	0.00681	CbGpPWpGaD
Abacavir—UGT1A1—Estrogen metabolism—GSTM1—kidney cancer	0.000908	0.00655	CbGpPWpGaD
Abacavir—ADH6—Biological oxidations—CYP1A1—kidney cancer	0.000895	0.00646	CbGpPWpGaD
Abacavir—UGT1A1—Estrogen metabolism—CYP1A1—kidney cancer	0.000861	0.00621	CbGpPWpGaD
Abacavir—UGT1A1—Irinotecan Pathway—APC—kidney cancer	0.000824	0.00594	CbGpPWpGaD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—JUND—kidney cancer	0.000816	0.00588	CbGpPWpGaD
Abacavir—ADH6—Metabolism—ACY1—kidney cancer	0.000788	0.00568	CbGpPWpGaD
Abacavir—UGT1A1—Biological oxidations—ACY1—kidney cancer	0.000728	0.00525	CbGpPWpGaD
Abacavir—ADH6—Metabolism—PDHB—kidney cancer	0.00067	0.00483	CbGpPWpGaD
Abacavir—ADH6—Biological oxidations—POMC—kidney cancer	0.000668	0.00481	CbGpPWpGaD
Abacavir—ADH6—Metabolism—CCBL1—kidney cancer	0.00063	0.00454	CbGpPWpGaD
Abacavir—UGT1A1—Constitutive Androstane Receptor Pathway—ABCB1—kidney cancer	0.00059	0.00426	CbGpPWpGaD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—JUNB—kidney cancer	0.000555	0.004	CbGpPWpGaD
Abacavir—ADH6—Metabolism—PPAT—kidney cancer	0.000546	0.00394	CbGpPWpGaD
Abacavir—ADH6—Metabolism—GLIPR1—kidney cancer	0.000546	0.00394	CbGpPWpGaD
Abacavir—ADH6—Metabolism—APRT—kidney cancer	0.000508	0.00366	CbGpPWpGaD
Abacavir—ADH6—Metabolism—FH—kidney cancer	0.000508	0.00366	CbGpPWpGaD
Abacavir—ADH6—Metabolism—GPC3—kidney cancer	0.000477	0.00344	CbGpPWpGaD
Abacavir—ADH6—Metabolism—CA2—kidney cancer	0.000464	0.00335	CbGpPWpGaD
Abacavir—ADH6—Metabolism—ALAD—kidney cancer	0.000452	0.00326	CbGpPWpGaD
Abacavir—ADH6—Metabolism—ST3GAL2—kidney cancer	0.000442	0.00318	CbGpPWpGaD
Abacavir—UGT1A1—NRF2 pathway—SLC5A3—kidney cancer	0.000436	0.00314	CbGpPWpGaD
Abacavir—ADH6—Metabolism—ALDH1A1—kidney cancer	0.000432	0.00311	CbGpPWpGaD
Abacavir—ADK—Metabolism—ACY1—kidney cancer	0.000421	0.00303	CbGpPWpGaD
Abacavir—ADH6—Metabolism—SLC5A3—kidney cancer	0.000414	0.00298	CbGpPWpGaD
Abacavir—ADH6—Metabolism—PGK1—kidney cancer	0.000414	0.00298	CbGpPWpGaD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—CYP1A1—kidney cancer	0.000406	0.00293	CbGpPWpGaD
Abacavir—ADH6—Metabolism—LDHB—kidney cancer	0.000406	0.00293	CbGpPWpGaD
Abacavir—UGT1A1—Phase II conjugation—GSTT1—kidney cancer	0.0004	0.00289	CbGpPWpGaD
Abacavir—UGT1A1—Biological oxidations—ALDH1A1—kidney cancer	0.000399	0.00287	CbGpPWpGaD
Abacavir—UGT1A1—NRF2 pathway—KEAP1—kidney cancer	0.000381	0.00275	CbGpPWpGaD
Abacavir—ADK—Metabolism—PDHB—kidney cancer	0.000358	0.00258	CbGpPWpGaD
Abacavir—ADH6—Metabolism—CA9—kidney cancer	0.000352	0.00254	CbGpPWpGaD
Abacavir—ADK—Metabolism—CCBL1—kidney cancer	0.000336	0.00242	CbGpPWpGaD
Abacavir—ADH6—Metabolism—CRABP1—kidney cancer	0.000299	0.00216	CbGpPWpGaD
Abacavir—ADK—Metabolism—GLIPR1—kidney cancer	0.000291	0.0021	CbGpPWpGaD
Abacavir—ADK—Metabolism—PPAT—kidney cancer	0.000291	0.0021	CbGpPWpGaD
Abacavir—ADH6—Metabolism—ITPR2—kidney cancer	0.000278	0.00201	CbGpPWpGaD
Abacavir—UGT1A1—Phase II conjugation—GSTP1—kidney cancer	0.000278	0.002	CbGpPWpGaD
Abacavir—ADK—Metabolism—APRT—kidney cancer	0.000271	0.00195	CbGpPWpGaD
Abacavir—ADK—Metabolism—FH—kidney cancer	0.000271	0.00195	CbGpPWpGaD
Abacavir—UGT1A1—Phase II conjugation—GSTM1—kidney cancer	0.000255	0.00184	CbGpPWpGaD
Abacavir—ADK—Metabolism—GPC3—kidney cancer	0.000255	0.00184	CbGpPWpGaD
Abacavir—ADH6—Metabolism—ACHE—kidney cancer	0.000254	0.00183	CbGpPWpGaD
Abacavir—ADH6—Metabolism—GSTT1—kidney cancer	0.000254	0.00183	CbGpPWpGaD
Abacavir—ADK—Metabolism—CA2—kidney cancer	0.000248	0.00179	CbGpPWpGaD
Abacavir—ADK—Metabolism—ALAD—kidney cancer	0.000242	0.00174	CbGpPWpGaD
Abacavir—ADH6—Metabolism—SCARB1—kidney cancer	0.00024	0.00173	CbGpPWpGaD
Abacavir—ADH6—Metabolism—PTGS1—kidney cancer	0.000238	0.00171	CbGpPWpGaD
Abacavir—ADK—Metabolism—ST3GAL2—kidney cancer	0.000236	0.0017	CbGpPWpGaD
Abacavir—UGT1A1—Biological oxidations—GSTT1—kidney cancer	0.000234	0.00169	CbGpPWpGaD
Abacavir—ADH6—Metabolism—PSMD7—kidney cancer	0.000233	0.00168	CbGpPWpGaD
Abacavir—ADK—Metabolism—ALDH1A1—kidney cancer	0.00023	0.00166	CbGpPWpGaD
Abacavir—UGT1A1—NRF2 pathway—SLC5A5—kidney cancer	0.00023	0.00166	CbGpPWpGaD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—kidney cancer	0.000229	0.00165	CbGpPWpGaD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL2—kidney cancer	0.000224	0.00162	CbGpPWpGaD
Abacavir—UGT1A1—NRF2 pathway—SLC2A1—kidney cancer	0.000222	0.0016	CbGpPWpGaD
Abacavir—ADH6—Metabolism—BCHE—kidney cancer	0.000221	0.00159	CbGpPWpGaD
Abacavir—ADK—Metabolism—SLC5A3—kidney cancer	0.000221	0.00159	CbGpPWpGaD
Abacavir—ADK—Metabolism—PGK1—kidney cancer	0.000221	0.00159	CbGpPWpGaD
Abacavir—UGT1A1—Biological oxidations—PTGS1—kidney cancer	0.00022	0.00158	CbGpPWpGaD
Abacavir—ADH6—Metabolism—SLC5A5—kidney cancer	0.000218	0.00157	CbGpPWpGaD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—JUN—kidney cancer	0.000218	0.00157	CbGpPWpGaD
Abacavir—ADK—Metabolism—LDHB—kidney cancer	0.000217	0.00156	CbGpPWpGaD
Abacavir—ADH6—Metabolism—SLC2A1—kidney cancer	0.000211	0.00152	CbGpPWpGaD
Abacavir—UGT1A1—NRF2 pathway—EGR1—kidney cancer	0.000206	0.00149	CbGpPWpGaD
Abacavir—ADK—Metabolism—CA9—kidney cancer	0.000188	0.00135	CbGpPWpGaD
Abacavir—UGT1A1—NRF2 pathway—GSTP1—kidney cancer	0.000185	0.00134	CbGpPWpGaD
Abacavir—ADH6—Metabolism—GSTP1—kidney cancer	0.000176	0.00127	CbGpPWpGaD
Abacavir—UGT1A1—NRF2 pathway—GSTM1—kidney cancer	0.00017	0.00123	CbGpPWpGaD
Abacavir—ADH6—Metabolism—ABCB1—kidney cancer	0.000166	0.0012	CbGpPWpGaD
Abacavir—Nervous system disorder—Gemcitabine—kidney cancer	0.000164	0.000612	CcSEcCtD
Abacavir—Thrombocytopenia—Gemcitabine—kidney cancer	0.000164	0.000611	CcSEcCtD
Abacavir—Feeling abnormal—Dactinomycin—kidney cancer	0.000163	0.000607	CcSEcCtD
Abacavir—Skin disorder—Gemcitabine—kidney cancer	0.000163	0.000606	CcSEcCtD
Abacavir—UGT1A1—Biological oxidations—GSTP1—kidney cancer	0.000162	0.00117	CbGpPWpGaD
Abacavir—Hepatitis—Capecitabine—kidney cancer	0.000162	0.000603	CcSEcCtD
Abacavir—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000162	0.000602	CcSEcCtD
Abacavir—ADH6—Metabolism—GSTM1—kidney cancer	0.000162	0.00116	CbGpPWpGaD
Abacavir—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000161	0.000599	CcSEcCtD
Abacavir—Pharyngitis—Capecitabine—kidney cancer	0.000161	0.000599	CcSEcCtD
Abacavir—UGT1A1—Metapathway biotransformation—GSTP1—kidney cancer	0.00016	0.00115	CbGpPWpGaD
Abacavir—Hypersensitivity—Sorafenib—kidney cancer	0.00016	0.000595	CcSEcCtD
Abacavir—Insomnia—Vincristine—kidney cancer	0.00016	0.000595	CcSEcCtD
Abacavir—Anorexia—Gemcitabine—kidney cancer	0.00016	0.000595	CcSEcCtD
Abacavir—ADK—Metabolism—CRABP1—kidney cancer	0.00016	0.00115	CbGpPWpGaD
Abacavir—Vomiting—Vinblastine—kidney cancer	0.00016	0.000594	CcSEcCtD
Abacavir—Dizziness—Erlotinib—kidney cancer	0.00016	0.000594	CcSEcCtD
Abacavir—Ill-defined disorder—Paclitaxel—kidney cancer	0.00016	0.000594	CcSEcCtD
Abacavir—Connective tissue disorder—Capecitabine—kidney cancer	0.000159	0.000593	CcSEcCtD
Abacavir—Vomiting—Everolimus—kidney cancer	0.000159	0.000592	CcSEcCtD
Abacavir—Anaemia—Paclitaxel—kidney cancer	0.000159	0.000591	CcSEcCtD
Abacavir—Paraesthesia—Vincristine—kidney cancer	0.000159	0.00059	CcSEcCtD
Abacavir—Rash—Everolimus—kidney cancer	0.000158	0.000587	CcSEcCtD
Abacavir—Dermatitis—Everolimus—kidney cancer	0.000158	0.000586	CcSEcCtD
Abacavir—Headache—Vinblastine—kidney cancer	0.000157	0.000585	CcSEcCtD
Abacavir—Headache—Everolimus—kidney cancer	0.000157	0.000583	CcSEcCtD
Abacavir—Hypotension—Gemcitabine—kidney cancer	0.000157	0.000583	CcSEcCtD
Abacavir—Body temperature increased—Dactinomycin—kidney cancer	0.000156	0.000582	CcSEcCtD
Abacavir—Abdominal pain—Dactinomycin—kidney cancer	0.000156	0.000582	CcSEcCtD
Abacavir—Asthenia—Sorafenib—kidney cancer	0.000156	0.00058	CcSEcCtD
Abacavir—Malaise—Paclitaxel—kidney cancer	0.000155	0.000577	CcSEcCtD
Abacavir—Vertigo—Paclitaxel—kidney cancer	0.000154	0.000575	CcSEcCtD
Abacavir—Lethargy—Doxorubicin—kidney cancer	0.000154	0.000574	CcSEcCtD
Abacavir—Leukopenia—Paclitaxel—kidney cancer	0.000154	0.000573	CcSEcCtD
Abacavir—Hypersensitivity—Sunitinib—kidney cancer	0.000154	0.000573	CcSEcCtD
Abacavir—Decreased appetite—Vincristine—kidney cancer	0.000154	0.000572	CcSEcCtD
Abacavir—Pruritus—Sorafenib—kidney cancer	0.000154	0.000572	CcSEcCtD
Abacavir—Vomiting—Erlotinib—kidney cancer	0.000153	0.000571	CcSEcCtD
Abacavir—Erythema multiforme—Capecitabine—kidney cancer	0.000153	0.00057	CcSEcCtD
Abacavir—ADH6—Metabolism—CYP1A1—kidney cancer	0.000153	0.0011	CbGpPWpGaD
Abacavir—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000153	0.000568	CcSEcCtD
Abacavir—Gastrointestinal disorder—Vincristine—kidney cancer	0.000153	0.000568	CcSEcCtD
Abacavir—Fatigue—Vincristine—kidney cancer	0.000152	0.000567	CcSEcCtD
Abacavir—Rash—Erlotinib—kidney cancer	0.000152	0.000566	CcSEcCtD
Abacavir—Dermatitis—Erlotinib—kidney cancer	0.000152	0.000566	CcSEcCtD
Abacavir—Insomnia—Gemcitabine—kidney cancer	0.000152	0.000564	CcSEcCtD
Abacavir—Headache—Erlotinib—kidney cancer	0.000151	0.000563	CcSEcCtD
Abacavir—Pain—Vincristine—kidney cancer	0.000151	0.000562	CcSEcCtD
Abacavir—Paraesthesia—Gemcitabine—kidney cancer	0.000151	0.00056	CcSEcCtD
Abacavir—Cough—Paclitaxel—kidney cancer	0.00015	0.000558	CcSEcCtD
Abacavir—Asthenia—Sunitinib—kidney cancer	0.00015	0.000558	CcSEcCtD
Abacavir—Dyspnoea—Gemcitabine—kidney cancer	0.000149	0.000556	CcSEcCtD
Abacavir—UGT1A1—Biological oxidations—GSTM1—kidney cancer	0.000149	0.00108	CbGpPWpGaD
Abacavir—Nausea—Vinblastine—kidney cancer	0.000149	0.000555	CcSEcCtD
Abacavir—Convulsion—Paclitaxel—kidney cancer	0.000149	0.000554	CcSEcCtD
Abacavir—Migraine—Doxorubicin—kidney cancer	0.000149	0.000553	CcSEcCtD
Abacavir—Nausea—Everolimus—kidney cancer	0.000149	0.000553	CcSEcCtD
Abacavir—Diarrhoea—Sorafenib—kidney cancer	0.000149	0.000553	CcSEcCtD
Abacavir—ADK—Metabolism—ITPR2—kidney cancer	0.000148	0.00107	CbGpPWpGaD
Abacavir—Pruritus—Sunitinib—kidney cancer	0.000148	0.00055	CcSEcCtD
Abacavir—UGT1A1—Metapathway biotransformation—GSTM1—kidney cancer	0.000147	0.00106	CbGpPWpGaD
Abacavir—Immune system disorder—Capecitabine—kidney cancer	0.000146	0.000545	CcSEcCtD
Abacavir—Arthralgia—Paclitaxel—kidney cancer	0.000146	0.000545	CcSEcCtD
Abacavir—Myalgia—Paclitaxel—kidney cancer	0.000146	0.000545	CcSEcCtD
Abacavir—Anxiety—Paclitaxel—kidney cancer	0.000146	0.000543	CcSEcCtD
Abacavir—Decreased appetite—Gemcitabine—kidney cancer	0.000146	0.000542	CcSEcCtD
Abacavir—Hypersensitivity—Dactinomycin—kidney cancer	0.000146	0.000542	CcSEcCtD
Abacavir—Chills—Capecitabine—kidney cancer	0.000145	0.000541	CcSEcCtD
Abacavir—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000145	0.000541	CcSEcCtD
Abacavir—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000145	0.000539	CcSEcCtD
Abacavir—Discomfort—Paclitaxel—kidney cancer	0.000145	0.000538	CcSEcCtD
Abacavir—Fatigue—Gemcitabine—kidney cancer	0.000145	0.000538	CcSEcCtD
Abacavir—Gastrointestinal pain—Vincristine—kidney cancer	0.000144	0.000538	CcSEcCtD
Abacavir—Dizziness—Sorafenib—kidney cancer	0.000144	0.000534	CcSEcCtD
Abacavir—Pain—Gemcitabine—kidney cancer	0.000143	0.000533	CcSEcCtD
Abacavir—Nausea—Erlotinib—kidney cancer	0.000143	0.000533	CcSEcCtD
Abacavir—Alopecia—Capecitabine—kidney cancer	0.000143	0.000533	CcSEcCtD
Abacavir—Diarrhoea—Sunitinib—kidney cancer	0.000143	0.000532	CcSEcCtD
Abacavir—Asthenia—Dactinomycin—kidney cancer	0.000142	0.000528	CcSEcCtD
Abacavir—Blood creatinine increased—Doxorubicin—kidney cancer	0.000142	0.000527	CcSEcCtD
Abacavir—UGT1A1—Biological oxidations—CYP1A1—kidney cancer	0.000141	0.00102	CbGpPWpGaD
Abacavir—Malnutrition—Capecitabine—kidney cancer	0.000141	0.000525	CcSEcCtD
Abacavir—Oedema—Paclitaxel—kidney cancer	0.00014	0.000522	CcSEcCtD
Abacavir—Anaphylactic shock—Paclitaxel—kidney cancer	0.00014	0.000522	CcSEcCtD
Abacavir—Body temperature increased—Vincristine—kidney cancer	0.00014	0.00052	CcSEcCtD
Abacavir—Abdominal pain—Vincristine—kidney cancer	0.00014	0.00052	CcSEcCtD
Abacavir—UGT1A1—Metapathway biotransformation—CYP1A1—kidney cancer	0.00014	0.00101	CbGpPWpGaD
Abacavir—Liver function test abnormal—Doxorubicin—kidney cancer	0.000139	0.000519	CcSEcCtD
Abacavir—Infection—Paclitaxel—kidney cancer	0.000139	0.000519	CcSEcCtD
Abacavir—Dizziness—Sunitinib—kidney cancer	0.000138	0.000514	CcSEcCtD
Abacavir—Feeling abnormal—Gemcitabine—kidney cancer	0.000138	0.000514	CcSEcCtD
Abacavir—Vomiting—Sorafenib—kidney cancer	0.000138	0.000514	CcSEcCtD
Abacavir—Abdominal pain upper—Doxorubicin—kidney cancer	0.000138	0.000513	CcSEcCtD
Abacavir—Nervous system disorder—Paclitaxel—kidney cancer	0.000138	0.000512	CcSEcCtD
Abacavir—Thrombocytopenia—Paclitaxel—kidney cancer	0.000137	0.000511	CcSEcCtD
Abacavir—Rash—Sorafenib—kidney cancer	0.000137	0.000509	CcSEcCtD
Abacavir—Dermatitis—Sorafenib—kidney cancer	0.000137	0.000509	CcSEcCtD
Abacavir—Skin disorder—Paclitaxel—kidney cancer	0.000136	0.000507	CcSEcCtD
Abacavir—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.000136	0.000506	CcSEcCtD
Abacavir—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	0.000136	0.000506	CcSEcCtD
Abacavir—Headache—Sorafenib—kidney cancer	0.000136	0.000506	CcSEcCtD
Abacavir—ADK—Metabolism—GSTT1—kidney cancer	0.000135	0.000976	CbGpPWpGaD
Abacavir—ADK—Metabolism—ACHE—kidney cancer	0.000135	0.000976	CbGpPWpGaD
Abacavir—Diarrhoea—Dactinomycin—kidney cancer	0.000135	0.000504	CcSEcCtD
Abacavir—Anorexia—Paclitaxel—kidney cancer	0.000134	0.000498	CcSEcCtD
Abacavir—Gastritis—Doxorubicin—kidney cancer	0.000134	0.000497	CcSEcCtD
Abacavir—Muscular weakness—Doxorubicin—kidney cancer	0.000133	0.000496	CcSEcCtD
Abacavir—Alanine aminotransferase increased—Doxorubicin—kidney cancer	0.000133	0.000496	CcSEcCtD
Abacavir—Vomiting—Sunitinib—kidney cancer	0.000133	0.000494	CcSEcCtD
Abacavir—Body temperature increased—Gemcitabine—kidney cancer	0.000133	0.000493	CcSEcCtD
Abacavir—Rash—Sunitinib—kidney cancer	0.000132	0.00049	CcSEcCtD
Abacavir—Dermatitis—Sunitinib—kidney cancer	0.000132	0.00049	CcSEcCtD
Abacavir—Hypotension—Paclitaxel—kidney cancer	0.000131	0.000488	CcSEcCtD
Abacavir—Ill-defined disorder—Capecitabine—kidney cancer	0.000131	0.000487	CcSEcCtD
Abacavir—Headache—Sunitinib—kidney cancer	0.000131	0.000487	CcSEcCtD
Abacavir—Anaemia—Capecitabine—kidney cancer	0.00013	0.000485	CcSEcCtD
Abacavir—Hypersensitivity—Vincristine—kidney cancer	0.00013	0.000484	CcSEcCtD
Abacavir—Nausea—Sorafenib—kidney cancer	0.000129	0.00048	CcSEcCtD
Abacavir—ADK—Metabolism—SCARB1—kidney cancer	0.000128	0.000924	CbGpPWpGaD
Abacavir—Pancreatitis—Doxorubicin—kidney cancer	0.000128	0.000476	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000128	0.000476	CcSEcCtD
Abacavir—Malaise—Capecitabine—kidney cancer	0.000127	0.000474	CcSEcCtD
Abacavir—Insomnia—Paclitaxel—kidney cancer	0.000127	0.000472	CcSEcCtD
Abacavir—ADK—Metabolism—PTGS1—kidney cancer	0.000127	0.000915	CbGpPWpGaD
Abacavir—Vertigo—Capecitabine—kidney cancer	0.000127	0.000472	CcSEcCtD
Abacavir—Asthenia—Vincristine—kidney cancer	0.000127	0.000472	CcSEcCtD
Abacavir—Leukopenia—Capecitabine—kidney cancer	0.000126	0.00047	CcSEcCtD
Abacavir—Paraesthesia—Paclitaxel—kidney cancer	0.000126	0.000469	CcSEcCtD
Abacavir—Vomiting—Dactinomycin—kidney cancer	0.000126	0.000468	CcSEcCtD
Abacavir—Bronchitis—Doxorubicin—kidney cancer	0.000126	0.000467	CcSEcCtD
Abacavir—Dyspnoea—Paclitaxel—kidney cancer	0.000125	0.000466	CcSEcCtD
Abacavir—Rash—Dactinomycin—kidney cancer	0.000125	0.000464	CcSEcCtD
Abacavir—UGT1A1—Metabolism—ACY1—kidney cancer	0.000124	0.000897	CbGpPWpGaD
Abacavir—ADK—Metabolism—PSMD7—kidney cancer	0.000124	0.000897	CbGpPWpGaD
Abacavir—Nausea—Sunitinib—kidney cancer	0.000124	0.000462	CcSEcCtD
Abacavir—Cough—Capecitabine—kidney cancer	0.000123	0.000458	CcSEcCtD
Abacavir—Neutropenia—Doxorubicin—kidney cancer	0.000122	0.000454	CcSEcCtD
Abacavir—Decreased appetite—Paclitaxel—kidney cancer	0.000122	0.000454	CcSEcCtD
Abacavir—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000121	0.000451	CcSEcCtD
Abacavir—Fatigue—Paclitaxel—kidney cancer	0.000121	0.00045	CcSEcCtD
Abacavir—Diarrhoea—Vincristine—kidney cancer	0.000121	0.00045	CcSEcCtD
Abacavir—Asthenia—Gemcitabine—kidney cancer	0.00012	0.000448	CcSEcCtD
Abacavir—Arthralgia—Capecitabine—kidney cancer	0.00012	0.000447	CcSEcCtD
Abacavir—Myalgia—Capecitabine—kidney cancer	0.00012	0.000447	CcSEcCtD
Abacavir—Pain—Paclitaxel—kidney cancer	0.00012	0.000447	CcSEcCtD
Abacavir—Anxiety—Capecitabine—kidney cancer	0.00012	0.000446	CcSEcCtD
Abacavir—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000119	0.000444	CcSEcCtD
Abacavir—Discomfort—Capecitabine—kidney cancer	0.000119	0.000442	CcSEcCtD
Abacavir—Pruritus—Gemcitabine—kidney cancer	0.000119	0.000441	CcSEcCtD
Abacavir—ADK—Metabolism—BCHE—kidney cancer	0.000118	0.000851	CbGpPWpGaD
Abacavir—Hyperglycaemia—Doxorubicin—kidney cancer	0.000118	0.000438	CcSEcCtD
Abacavir—Nausea—Dactinomycin—kidney cancer	0.000117	0.000437	CcSEcCtD
Abacavir—Pneumonia—Doxorubicin—kidney cancer	0.000117	0.000436	CcSEcCtD
Abacavir—Dizziness—Vincristine—kidney cancer	0.000117	0.000435	CcSEcCtD
Abacavir—ADK—Metabolism—SLC5A5—kidney cancer	0.000117	0.00084	CbGpPWpGaD
Abacavir—Feeling abnormal—Paclitaxel—kidney cancer	0.000116	0.00043	CcSEcCtD
Abacavir—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.000115	0.000429	CcSEcCtD
Abacavir—Oedema—Capecitabine—kidney cancer	0.000115	0.000429	CcSEcCtD
Abacavir—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000115	0.000427	CcSEcCtD
Abacavir—Diarrhoea—Gemcitabine—kidney cancer	0.000115	0.000427	CcSEcCtD
Abacavir—Renal failure—Doxorubicin—kidney cancer	0.000114	0.000426	CcSEcCtD
Abacavir—Infection—Capecitabine—kidney cancer	0.000114	0.000426	CcSEcCtD
Abacavir—ADH6—Metabolism—POMC—kidney cancer	0.000114	0.000823	CbGpPWpGaD
Abacavir—Neuropathy peripheral—Doxorubicin—kidney cancer	0.000114	0.000425	CcSEcCtD
Abacavir—Stomatitis—Doxorubicin—kidney cancer	0.000113	0.000422	CcSEcCtD
Abacavir—Conjunctivitis—Doxorubicin—kidney cancer	0.000113	0.000421	CcSEcCtD
Abacavir—Nervous system disorder—Capecitabine—kidney cancer	0.000113	0.00042	CcSEcCtD
Abacavir—Thrombocytopenia—Capecitabine—kidney cancer	0.000113	0.00042	CcSEcCtD
Abacavir—ADK—Metabolism—SLC2A1—kidney cancer	0.000113	0.000812	CbGpPWpGaD
Abacavir—Vomiting—Vincristine—kidney cancer	0.000112	0.000418	CcSEcCtD
Abacavir—Skin disorder—Capecitabine—kidney cancer	0.000112	0.000416	CcSEcCtD
Abacavir—Urticaria—Paclitaxel—kidney cancer	0.000111	0.000415	CcSEcCtD
Abacavir—Rash—Vincristine—kidney cancer	0.000111	0.000415	CcSEcCtD
Abacavir—Dermatitis—Vincristine—kidney cancer	0.000111	0.000414	CcSEcCtD
Abacavir—Abdominal pain—Paclitaxel—kidney cancer	0.000111	0.000413	CcSEcCtD
Abacavir—Body temperature increased—Paclitaxel—kidney cancer	0.000111	0.000413	CcSEcCtD
Abacavir—Headache—Vincristine—kidney cancer	0.000111	0.000412	CcSEcCtD
Abacavir—Hepatobiliary disease—Doxorubicin—kidney cancer	0.00011	0.00041	CcSEcCtD
Abacavir—Anorexia—Capecitabine—kidney cancer	0.00011	0.000409	CcSEcCtD
Abacavir—Hypotension—Capecitabine—kidney cancer	0.000108	0.000401	CcSEcCtD
Abacavir—Vomiting—Gemcitabine—kidney cancer	0.000107	0.000397	CcSEcCtD
Abacavir—UGT1A1—Metabolism—PDHB—kidney cancer	0.000106	0.000763	CbGpPWpGaD
Abacavir—Rash—Gemcitabine—kidney cancer	0.000106	0.000393	CcSEcCtD
Abacavir—Dermatitis—Gemcitabine—kidney cancer	0.000106	0.000393	CcSEcCtD
Abacavir—UGT1A1—Biological oxidations—POMC—kidney cancer	0.000105	0.000761	CbGpPWpGaD
Abacavir—Headache—Gemcitabine—kidney cancer	0.000105	0.000391	CcSEcCtD
Abacavir—Nausea—Vincristine—kidney cancer	0.000105	0.000391	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000105	0.000391	CcSEcCtD
Abacavir—Hepatitis—Doxorubicin—kidney cancer	0.000104	0.000389	CcSEcCtD
Abacavir—Insomnia—Capecitabine—kidney cancer	0.000104	0.000388	CcSEcCtD
Abacavir—Pharyngitis—Doxorubicin—kidney cancer	0.000104	0.000386	CcSEcCtD
Abacavir—Paraesthesia—Capecitabine—kidney cancer	0.000103	0.000385	CcSEcCtD
Abacavir—Hypersensitivity—Paclitaxel—kidney cancer	0.000103	0.000385	CcSEcCtD
Abacavir—Connective tissue disorder—Doxorubicin—kidney cancer	0.000103	0.000382	CcSEcCtD
Abacavir—Dyspnoea—Capecitabine—kidney cancer	0.000103	0.000382	CcSEcCtD
Abacavir—Asthenia—Paclitaxel—kidney cancer	0.000101	0.000375	CcSEcCtD
Abacavir—Decreased appetite—Capecitabine—kidney cancer	0.0001	0.000373	CcSEcCtD
Abacavir—Nausea—Gemcitabine—kidney cancer	9.96e-05	0.000371	CcSEcCtD
Abacavir—UGT1A1—Metabolism—CCBL1—kidney cancer	9.95e-05	0.000717	CbGpPWpGaD
Abacavir—Gastrointestinal disorder—Capecitabine—kidney cancer	9.94e-05	0.00037	CcSEcCtD
Abacavir—Fatigue—Capecitabine—kidney cancer	9.93e-05	0.00037	CcSEcCtD
Abacavir—Pruritus—Paclitaxel—kidney cancer	9.93e-05	0.00037	CcSEcCtD
Abacavir—Erythema multiforme—Doxorubicin—kidney cancer	9.88e-05	0.000368	CcSEcCtD
Abacavir—Pain—Capecitabine—kidney cancer	9.85e-05	0.000367	CcSEcCtD
Abacavir—Diarrhoea—Paclitaxel—kidney cancer	9.6e-05	0.000357	CcSEcCtD
Abacavir—Feeling abnormal—Capecitabine—kidney cancer	9.49e-05	0.000353	CcSEcCtD
Abacavir—Immune system disorder—Doxorubicin—kidney cancer	9.44e-05	0.000351	CcSEcCtD
Abacavir—Gastrointestinal pain—Capecitabine—kidney cancer	9.42e-05	0.00035	CcSEcCtD
Abacavir—ADK—Metabolism—GSTP1—kidney cancer	9.39e-05	0.000677	CbGpPWpGaD
Abacavir—Chills—Doxorubicin—kidney cancer	9.38e-05	0.000349	CcSEcCtD
Abacavir—Dizziness—Paclitaxel—kidney cancer	9.28e-05	0.000345	CcSEcCtD
Abacavir—Alopecia—Doxorubicin—kidney cancer	9.23e-05	0.000344	CcSEcCtD
Abacavir—Urticaria—Capecitabine—kidney cancer	9.15e-05	0.000341	CcSEcCtD
Abacavir—ADH6—Metabolism—PTGS2—kidney cancer	9.11e-05	0.000657	CbGpPWpGaD
Abacavir—Body temperature increased—Capecitabine—kidney cancer	9.1e-05	0.000339	CcSEcCtD
Abacavir—Abdominal pain—Capecitabine—kidney cancer	9.1e-05	0.000339	CcSEcCtD
Abacavir—Malnutrition—Doxorubicin—kidney cancer	9.1e-05	0.000339	CcSEcCtD
Abacavir—Vomiting—Paclitaxel—kidney cancer	8.92e-05	0.000332	CcSEcCtD
Abacavir—ADK—Metabolism—ABCB1—kidney cancer	8.88e-05	0.000641	CbGpPWpGaD
Abacavir—Rash—Paclitaxel—kidney cancer	8.85e-05	0.000329	CcSEcCtD
Abacavir—Dermatitis—Paclitaxel—kidney cancer	8.84e-05	0.000329	CcSEcCtD
Abacavir—Headache—Paclitaxel—kidney cancer	8.79e-05	0.000327	CcSEcCtD
Abacavir—UGT1A1—Metabolism—PPAT—kidney cancer	8.62e-05	0.000622	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—GLIPR1—kidney cancer	8.62e-05	0.000622	CbGpPWpGaD
Abacavir—ADK—Metabolism—GSTM1—kidney cancer	8.62e-05	0.000622	CbGpPWpGaD
Abacavir—Hypersensitivity—Capecitabine—kidney cancer	8.49e-05	0.000316	CcSEcCtD
Abacavir—Ill-defined disorder—Doxorubicin—kidney cancer	8.44e-05	0.000314	CcSEcCtD
Abacavir—Anaemia—Doxorubicin—kidney cancer	8.41e-05	0.000313	CcSEcCtD
Abacavir—Nausea—Paclitaxel—kidney cancer	8.34e-05	0.00031	CcSEcCtD
Abacavir—Asthenia—Capecitabine—kidney cancer	8.26e-05	0.000308	CcSEcCtD
Abacavir—Malaise—Doxorubicin—kidney cancer	8.2e-05	0.000305	CcSEcCtD
Abacavir—ADK—Metabolism—CYP1A1—kidney cancer	8.18e-05	0.00059	CbGpPWpGaD
Abacavir—Vertigo—Doxorubicin—kidney cancer	8.17e-05	0.000304	CcSEcCtD
Abacavir—Pruritus—Capecitabine—kidney cancer	8.15e-05	0.000303	CcSEcCtD
Abacavir—Leukopenia—Doxorubicin—kidney cancer	8.14e-05	0.000303	CcSEcCtD
Abacavir—UGT1A1—Metabolism—FH—kidney cancer	8.02e-05	0.000578	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—APRT—kidney cancer	8.02e-05	0.000578	CbGpPWpGaD
Abacavir—ADH6—Metabolism—PTEN—kidney cancer	7.94e-05	0.000573	CbGpPWpGaD
Abacavir—Cough—Doxorubicin—kidney cancer	7.94e-05	0.000295	CcSEcCtD
Abacavir—Convulsion—Doxorubicin—kidney cancer	7.88e-05	0.000293	CcSEcCtD
Abacavir—Diarrhoea—Capecitabine—kidney cancer	7.88e-05	0.000293	CcSEcCtD
Abacavir—Myalgia—Doxorubicin—kidney cancer	7.74e-05	0.000288	CcSEcCtD
Abacavir—Arthralgia—Doxorubicin—kidney cancer	7.74e-05	0.000288	CcSEcCtD
Abacavir—Anxiety—Doxorubicin—kidney cancer	7.72e-05	0.000287	CcSEcCtD
Abacavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	7.69e-05	0.000286	CcSEcCtD
Abacavir—Discomfort—Doxorubicin—kidney cancer	7.65e-05	0.000285	CcSEcCtD
Abacavir—Dizziness—Capecitabine—kidney cancer	7.62e-05	0.000283	CcSEcCtD
Abacavir—UGT1A1—Metabolism—GPC3—kidney cancer	7.54e-05	0.000544	CbGpPWpGaD
Abacavir—Oedema—Doxorubicin—kidney cancer	7.42e-05	0.000276	CcSEcCtD
Abacavir—Anaphylactic shock—Doxorubicin—kidney cancer	7.42e-05	0.000276	CcSEcCtD
Abacavir—Infection—Doxorubicin—kidney cancer	7.38e-05	0.000274	CcSEcCtD
Abacavir—UGT1A1—Metabolism—CA2—kidney cancer	7.33e-05	0.000529	CbGpPWpGaD
Abacavir—Vomiting—Capecitabine—kidney cancer	7.32e-05	0.000273	CcSEcCtD
Abacavir—Nervous system disorder—Doxorubicin—kidney cancer	7.28e-05	0.000271	CcSEcCtD
Abacavir—Thrombocytopenia—Doxorubicin—kidney cancer	7.27e-05	0.000271	CcSEcCtD
Abacavir—Rash—Capecitabine—kidney cancer	7.26e-05	0.00027	CcSEcCtD
Abacavir—Dermatitis—Capecitabine—kidney cancer	7.25e-05	0.00027	CcSEcCtD
Abacavir—Headache—Capecitabine—kidney cancer	7.21e-05	0.000269	CcSEcCtD
Abacavir—Skin disorder—Doxorubicin—kidney cancer	7.21e-05	0.000268	CcSEcCtD
Abacavir—UGT1A1—Metabolism—ALAD—kidney cancer	7.15e-05	0.000515	CbGpPWpGaD
Abacavir—Anorexia—Doxorubicin—kidney cancer	7.08e-05	0.000263	CcSEcCtD
Abacavir—UGT1A1—Metabolism—ST3GAL2—kidney cancer	6.98e-05	0.000503	CbGpPWpGaD
Abacavir—Hypotension—Doxorubicin—kidney cancer	6.94e-05	0.000258	CcSEcCtD
Abacavir—Nausea—Capecitabine—kidney cancer	6.84e-05	0.000255	CcSEcCtD
Abacavir—UGT1A1—Metabolism—ALDH1A1—kidney cancer	6.82e-05	0.000492	CbGpPWpGaD
Abacavir—Musculoskeletal discomfort—Doxorubicin—kidney cancer	6.76e-05	0.000252	CcSEcCtD
Abacavir—Insomnia—Doxorubicin—kidney cancer	6.71e-05	0.00025	CcSEcCtD
Abacavir—Paraesthesia—Doxorubicin—kidney cancer	6.67e-05	0.000248	CcSEcCtD
Abacavir—Dyspnoea—Doxorubicin—kidney cancer	6.62e-05	0.000246	CcSEcCtD
Abacavir—UGT1A1—Metabolism—SLC5A3—kidney cancer	6.54e-05	0.000471	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—PGK1—kidney cancer	6.54e-05	0.000471	CbGpPWpGaD
Abacavir—Decreased appetite—Doxorubicin—kidney cancer	6.45e-05	0.00024	CcSEcCtD
Abacavir—UGT1A1—Metabolism—LDHB—kidney cancer	6.41e-05	0.000462	CbGpPWpGaD
Abacavir—Gastrointestinal disorder—Doxorubicin—kidney cancer	6.41e-05	0.000239	CcSEcCtD
Abacavir—Fatigue—Doxorubicin—kidney cancer	6.4e-05	0.000238	CcSEcCtD
Abacavir—Pain—Doxorubicin—kidney cancer	6.35e-05	0.000236	CcSEcCtD
Abacavir—Feeling abnormal—Doxorubicin—kidney cancer	6.12e-05	0.000228	CcSEcCtD
Abacavir—ADK—Metabolism—POMC—kidney cancer	6.1e-05	0.00044	CbGpPWpGaD
Abacavir—Gastrointestinal pain—Doxorubicin—kidney cancer	6.07e-05	0.000226	CcSEcCtD
Abacavir—Urticaria—Doxorubicin—kidney cancer	5.9e-05	0.000219	CcSEcCtD
Abacavir—Abdominal pain—Doxorubicin—kidney cancer	5.87e-05	0.000218	CcSEcCtD
Abacavir—Body temperature increased—Doxorubicin—kidney cancer	5.87e-05	0.000218	CcSEcCtD
Abacavir—ADH6—Metabolism—PIK3CA—kidney cancer	5.6e-05	0.000404	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—CA9—kidney cancer	5.56e-05	0.000401	CbGpPWpGaD
Abacavir—Hypersensitivity—Doxorubicin—kidney cancer	5.47e-05	0.000204	CcSEcCtD
Abacavir—Asthenia—Doxorubicin—kidney cancer	5.33e-05	0.000198	CcSEcCtD
Abacavir—Pruritus—Doxorubicin—kidney cancer	5.25e-05	0.000195	CcSEcCtD
Abacavir—Diarrhoea—Doxorubicin—kidney cancer	5.08e-05	0.000189	CcSEcCtD
Abacavir—Dizziness—Doxorubicin—kidney cancer	4.91e-05	0.000183	CcSEcCtD
Abacavir—ADK—Metabolism—PTGS2—kidney cancer	4.86e-05	0.000351	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—CRABP1—kidney cancer	4.73e-05	0.000341	CbGpPWpGaD
Abacavir—Vomiting—Doxorubicin—kidney cancer	4.72e-05	0.000176	CcSEcCtD
Abacavir—Rash—Doxorubicin—kidney cancer	4.68e-05	0.000174	CcSEcCtD
Abacavir—Dermatitis—Doxorubicin—kidney cancer	4.68e-05	0.000174	CcSEcCtD
Abacavir—Headache—Doxorubicin—kidney cancer	4.65e-05	0.000173	CcSEcCtD
Abacavir—Nausea—Doxorubicin—kidney cancer	4.41e-05	0.000164	CcSEcCtD
Abacavir—UGT1A1—Metabolism—ITPR2—kidney cancer	4.39e-05	0.000317	CbGpPWpGaD
Abacavir—ADK—Metabolism—PTEN—kidney cancer	4.24e-05	0.000306	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—GSTT1—kidney cancer	4.01e-05	0.000289	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—ACHE—kidney cancer	4.01e-05	0.000289	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—SCARB1—kidney cancer	3.79e-05	0.000273	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—PTGS1—kidney cancer	3.75e-05	0.000271	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—PSMD7—kidney cancer	3.68e-05	0.000265	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—BCHE—kidney cancer	3.49e-05	0.000252	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—SLC5A5—kidney cancer	3.45e-05	0.000249	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—SLC2A1—kidney cancer	3.33e-05	0.00024	CbGpPWpGaD
Abacavir—ADK—Metabolism—PIK3CA—kidney cancer	2.99e-05	0.000216	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—GSTP1—kidney cancer	2.78e-05	0.0002	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—ABCB1—kidney cancer	2.63e-05	0.00019	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—GSTM1—kidney cancer	2.55e-05	0.000184	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—CYP1A1—kidney cancer	2.42e-05	0.000174	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—POMC—kidney cancer	1.8e-05	0.00013	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—PTGS2—kidney cancer	1.44e-05	0.000104	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—PTEN—kidney cancer	1.25e-05	9.05e-05	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—PIK3CA—kidney cancer	8.85e-06	6.38e-05	CbGpPWpGaD
